Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

The role of haptoglobin and hemopexin in the prevention of delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage: a review of current literature.

Griffiths S, Clark J, Adamides AA, Ziogas J.

Neurosurg Rev. 2019 Sep 6. doi: 10.1007/s10143-019-01169-2. [Epub ahead of print] Review.

PMID:
31493061
2.

Sez6 levels are elevated in cerebrospinal fluid of patients with inflammatory pain-associated conditions.

Roitman M, Edgington-Mitchell LE, Mangum J, Ziogas J, Adamides AA, Myles P, Choo-Bunnett H, Bunnett NW, Gunnersen JM.

Pain Rep. 2019 Mar 25;4(2):e719. doi: 10.1097/PR9.0000000000000719. eCollection 2019 Mar-Apr.

3.

Association of copeptin, a surrogate marker of arginine vasopressin, with cerebral vasospasm and delayed ischemic neurologic deficit after aneurysmal subarachnoid hemorrhage.

Fernandez SJ, Barakat I, Ziogas J, Frugier T, Stylli SS, Laidlaw JD, Kaye AH, Adamides AA.

J Neurosurg. 2018 May 4:1-7. doi: 10.3171/2017.10.JNS17795. [Epub ahead of print]

PMID:
29726784
4.

Sputum Active Polymyxin Lipopeptides: Activity against Cystic Fibrosis Pseudomonas aeruginosa Isolates and Their Interactions with Sputum Biomolecules.

Schneider-Futschik EK, Paulin OKA, Hoyer D, Roberts KD, Ziogas J, Baker MA, Karas J, Li J, Velkov T.

ACS Infect Dis. 2018 May 11;4(5):646-655. doi: 10.1021/acsinfecdis.7b00238. Epub 2018 Apr 2.

5.

miRNA expression profiling of cerebrospinal fluid in patients with aneurysmal subarachnoid hemorrhage.

Stylli SS, Adamides AA, Koldej RM, Luwor RB, Ritchie DS, Ziogas J, Kaye AH.

J Neurosurg. 2017 Apr;126(4):1131-1139. doi: 10.3171/2016.1.JNS151454. Epub 2016 Apr 29.

PMID:
27128592
6.

High-resolution twin-ion metabolite extraction (HiTIME) mass spectrometry: nontargeted detection of unknown drug metabolites by isotope labeling, liquid chromatography mass spectrometry, and automated high-performance computing.

Leeming MG, Isaac AP, Pope BJ, Cranswick N, Wright CE, Ziogas J, O'Hair RA, Donald WA.

Anal Chem. 2015 Apr 21;87(8):4104-9. doi: 10.1021/ac504767d. Epub 2015 Apr 8.

PMID:
25818563
7.

The role of voltage-operated and non-voltage-operated calcium channels in endothelin-induced vasoconstriction of rat cerebral arteries.

Mamo YA, Angus JA, Ziogas J, Soeding PF, Wright CE.

Eur J Pharmacol. 2014 Nov 5;742:65-73. doi: 10.1016/j.ejphar.2014.09.002. Epub 2014 Sep 9.

PMID:
25218985
8.

Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes.

Shand FH, Ueha S, Otsuji M, Koid SS, Shichino S, Tsukui T, Kosugi-Kanaya M, Abe J, Tomura M, Ziogas J, Matsushima K.

Proc Natl Acad Sci U S A. 2014 May 27;111(21):7771-6. doi: 10.1073/pnas.1402914111. Epub 2014 May 13.

9.

Aliskiren reduces myocardial ischemia-reperfusion injury by a bradykinin B2 receptor- and angiotensin AT2 receptor-mediated mechanism.

Koid SS, Ziogas J, Campbell DJ.

Hypertension. 2014 Apr;63(4):768-73. doi: 10.1161/HYPERTENSIONAHA.113.02902. Epub 2014 Jan 13.

PMID:
24420538
10.

An evaluation of pharmacology curricula in Australian science and health-related degree programs.

Lloyd H, Hinton T, Bullock S, Babey AM, Davis E, Fernandes L, Hart J, Musgrave I, Ziogas J.

BMC Med Educ. 2013 Nov 19;13:153. doi: 10.1186/1472-6920-13-153.

11.

Dual action molecules: bioassays of combined novel antioxidants and angiotensin II receptor antagonists.

Jani NV, Ziogas J, Angus JA, Schiesser CH, Macdougall PE, Grange RL, Wright CE.

Eur J Pharmacol. 2012 Nov 15;695(1-3):96-103. doi: 10.1016/j.ejphar.2012.08.003. Epub 2012 Sep 10.

PMID:
22975712
12.

Exogenous glutathione is essential in the testing of antioxidant capacity using radical-induced haemolysis.

Jani N, Ziogas J, Angus JA, Wright CE.

J Pharmacol Toxicol Methods. 2012 May-Jun;65(3):142-6. doi: 10.1016/j.vascn.2012.03.006. Epub 2012 Apr 1.

PMID:
22507255
13.

Novel paramagnetic AT1 receptor antagonists.

Tan NP, Taylor MK, Bottle SE, Wright CE, Ziogas J, White JM, Schiesser CH, Jani NV.

Chem Commun (Camb). 2011 Nov 28;47(44):12083-5. doi: 10.1039/c1cc14920b. Epub 2011 Sep 30.

PMID:
21963998
14.

In vitro and in vivo evidence for anti-inflammatory properties of 2-methoxyestradiol.

Shand FH, Langenbach SY, Keenan CR, Ma SP, Wheaton BJ, Schuliga MJ, Ziogas J, Stewart AG.

J Pharmacol Exp Ther. 2011 Mar;336(3):962-72. doi: 10.1124/jpet.110.174854. Epub 2010 Dec 21.

PMID:
21177477
15.

Tandem free-radical addition/substitution chemistry and its application to the preparation of novel AT1 receptor antagonists.

Staples MK, Grange RL, Angus JA, Ziogas J, Tan NP, Taylor MK, Schiesser CH.

Org Biomol Chem. 2011 Jan 21;9(2):473-9. doi: 10.1039/c0ob00573h. Epub 2010 Nov 3.

PMID:
21049134
16.

Ligand-supported purification of the urotensin-II receptor.

Du AT, Onan D, Dinh DT, Lew MJ, Ziogas J, Aguilar MI, Pattenden LK, Thomas WG.

Mol Pharmacol. 2010 Oct;78(4):639-47. doi: 10.1124/mol.110.065151. Epub 2010 Jul 20.

PMID:
20647393
17.

Collagen remodelling by airway smooth muscle is resistant to steroids and β₂-agonists.

Bourke JE, Li X, Foster SR, Wee E, Dagher H, Ziogas J, Harris T, Bonacci JV, Stewart AG.

Eur Respir J. 2011 Jan;37(1):173-82. doi: 10.1183/09031936.00008109. Epub 2010 Jul 1.

18.

Selenosartans: novel selenophene analogues of milfasartan and eprosartan.

Grange RL, Ziogas J, North AJ, Angus JA, Schiesser CH.

Bioorg Med Chem Lett. 2008 Feb 1;18(3):1241-4. doi: 10.1016/j.bmcl.2007.11.136. Epub 2008 Jan 1.

PMID:
18191398
19.

2-Methoxyestradiol--a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents.

Sutherland TE, Anderson RL, Hughes RA, Altmann E, Schuliga M, Ziogas J, Stewart AG.

Drug Discov Today. 2007 Jul;12(13-14):577-84. Epub 2007 Jun 26. Review.

PMID:
17631253
20.

Molecular and cellular targets in tissue remodelling.

Stewart AG, Ziogas J.

Pulm Pharmacol Ther. 2006;19(1):1-2. No abstract available.

PMID:
16432925
21.
22.
23.

Involvement of T-type calcium channels in excitatory junction potentials in rat resistance mesenteric arteries.

Xi Q, Ziogas J, Roberts JA, Evans RJ, Angus JA.

Br J Pharmacol. 2002 Nov;137(6):805-12.

24.

Neuronal NO mediates cerebral vasodilator responses to K+ in hypertensive rats.

Chrissobolis S, Ziogas J, Anderson CR, Chu Y, Faraci FM, Sobey CG.

Hypertension. 2002 Apr;39(4):880-5.

PMID:
11967243
25.

Side-chain substitutions within angiotensin II reveal different requirements for signaling, internalization, and phosphorylation of type 1A angiotensin receptors.

Holloway AC, Qian H, Pipolo L, Ziogas J, Miura S, Karnik S, Southwell BR, Lew MJ, Thomas WG.

Mol Pharmacol. 2002 Apr;61(4):768-77.

PMID:
11901215
26.

Insurmountable AT1 receptor antagonism: message in a model?

Lew M, Christopoulos A, Ziogas J.

Trends Pharmacol Sci. 2001 Nov;22(11):555-7. No abstract available.

PMID:
11698095
28.

Role of inwardly rectifying K(+) channels in K(+)-induced cerebral vasodilatation in vivo.

Chrissobolis S, Ziogas J, Chu Y, Faraci FM, Sobey CG.

Am J Physiol Heart Circ Physiol. 2000 Dec;279(6):H2704-12.

29.

Dynamic mechanisms of non-classical antagonism by competitive AT(1) receptor antagonists.

Lew MJ, Ziogas J, Christopoulos A.

Trends Pharmacol Sci. 2000 Oct;21(10):376-81. Review.

PMID:
11050317
32.
34.

Caffeine enhances sympathetic purinergic and noradrenergic transmission in the guinea-pig isolated vas deferens.

Ziogas J, O'Farrell M, Slaughter M.

Naunyn Schmiedebergs Arch Pharmacol. 1995 Nov;352(5):497-505.

PMID:
8751078
37.

Angiotensin II generation in the rat vena cava: stimulation of local synthesis by beta-adrenoceptor activation.

Ziogas J, Story DF.

Naunyn Schmiedebergs Arch Pharmacol. 1991 Jan;343(1):31-6.

PMID:
1851541
38.

Metabolism of tetradecapeptide, angiotensinogen and angiotensin I and II by isolated perfused rat hindlimbs.

Campbell DJ, Ziogas J, Kladis A.

Clin Exp Pharmacol Physiol. 1990 May;17(5):335-50.

PMID:
2191795
39.
40.

Inhibition of transmitter release from sympathetic nerve endings by omega-conotoxin.

Brock JA, Cunnane TC, Evans RJ, Ziogas J.

Clin Exp Pharmacol Physiol. 1989 Apr;16(4):333-9.

PMID:
2568204
41.
42.
43.

Modulation of neuroeffector transmission.

Rand MJ, Majewski H, Wong-Dusting H, Story DF, Loiacono RE, Ziogas J.

J Cardiovasc Pharmacol. 1987;10 Suppl 12:S33-44. Review.

PMID:
2455191
44.
46.

Effects of locally generated angiotensin II on noradrenergic transmission in guinea-pig isolated atria.

Ziogas J, Story DF, Rand MJ.

Eur J Pharmacol. 1984 Oct 30;106(1):11-8.

PMID:
6099265
47.

Supplemental Content

Loading ...
Support Center